BioLineRX Ltd BLRX

$2.93 +2.81% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K 6-K 2026-08-18 View →
6-K 6-K 2026-07-08 View →
6-K 6-K 2026-05-27 View →
6-K 6-K 2026-05-22 View →
6-K 6-K 2026-05-19 View →
6-K 6-K 2026-04-28 View →
6-K 6-K 2026-03-26 View →
6-K 6-K 2026-03-23 View →
20-F 20-F 2026-03-23 View →
6-K 6-K 2026-02-23 View →
6-K 6-K 2025-11-24 View →
6-K 6-K 2025-11-17 View →
6-K 6-K 2025-09-29 View →
6-K 6-K 2025-08-14 View →
424B5 424B5 2025-07-25 View →
6-K 6-K 2025-06-30 View →
6-K 6-K 2025-05-30 View →
6-K 6-K 2025-05-27 View →
6-K 6-K 2025-05-23 View →
424B5 424B5 2025-04-11 View →
6-K 6-K 2025-03-31 View →
20-F 20-F 2025-03-31 View →
6-K 6-K 2025-01-21 View →
6-K 6-K 2025-01-17 View →
6-K 6-K 2025-01-07 View →
424B5 424B5 2025-01-07 View →
6-K 6-K 2025-01-06 View →
6-K 6-K 2024-11-25 View →
6-K 6-K 2024-11-21 View →
424B5 424B5 2024-11-21 View →
6-K 6-K 2024-11-12 View →
6-K 6-K 2024-11-05 View →
6-K 6-K 2024-10-16 View →
6-K 6-K 2024-10-01 View →
6-K 6-K 2024-08-19 View →
6-K 6-K 2024-08-15 View →
6-K 6-K 2024-06-18 View →
6-K 6-K 2024-05-30 View →
6-K 6-K 2024-05-28 View →
6-K 6-K 2024-05-24 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.93
Market Cap
$12.40 million
52-Week Range
$2.15 – $4.75
Average Volume
9K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.